This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.